Earnings Feed
Start Free
$QDEL·8-K

QuidelOrtho Corp · Jun 23, 4:04 PM ET

Compare

QuidelOrtho Corp 8-K

Research Summary

AI-generated summary

Updated

QuidelOrtho Appoints New CFO Micah Young, Effective July 6, 2026

What Happened
QuidelOrtho Corporation announced the appointment of Micah Young as Chief Financial Officer and principal financial officer, effective July 6, 2026. Mr. Young succeeds Joseph M. Busky, who previously announced his retirement and will remain through the transition before serving as a paid special advisor. The company furnished a press release on June 23, 2026 and filed the offer letter dated June 22, 2026 as an exhibit to the 8-K.

Key Details

  • Annual base salary: $750,000; annual target cash bonus: 100% of base salary.
  • Sign-on: $500,000 cash plus a one-time inducement RSU grant valued at $6,500,000 vesting in equal annual installments over 3 years.
  • Expected 2027 equity grant value: $5,000,000 (50% time-based RSUs; 50% non-qualified stock options).
  • Severance/CIC protection: for non-CIC termination, generally 2x (base + bonus), up to 2 years of benefits continuation and $25,000 for fees; for CIC qualifying termination, same benefits plus full vesting/acceleration of unvested equity.
  • Background: Mr. Young (age 48) was EVP & CFO of Masimo through its June 2026 acquisition by Danaher; prior finance roles at NuVasive and Zimmer; B.S. in Accounting & Criminal Justice; CPA (inactive).
  • Transition for outgoing CFO Joseph Busky: paid at $340,000 annual base for six months after the effective date, then may serve up to 24 months as special advisor at $100,000/year; eligible for 2026 bonus only; existing equity awards continue to vest per their terms.

Why It Matters
This is a material leadership change for QuidelOrtho’s finance function with a defined transition plan to reduce disruption. The new CFO’s compensation package includes substantial up-front equity (RSUs valued at $6.5M) and future equity opportunities, which could affect future compensation expense and potential share dilution as awards vest or are exercised. Investors should note the severance and change-in-control protections align Mr. Young’s incentives with continuity and provide standard executive protections disclosed in the filing.

Loading document...